Virtus ETF Advisers’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,785
| Closed | -$166K | – | 418 |
|
|
2021
Q4 | $166K | Sell |
1,785
-1,393
| -44% | -$91.8K | 0.06% | 306 |
|
|
2021
Q3 | $189K | Sell |
3,178
-172
| -5% | -$10.2K | 0.08% | 283 |
|
|
2021
Q2 | $228K | Sell |
3,350
-923
| -22% | -$60.2K | 0.09% | 253 |
|
|
2021
Q1 | $297K | Buy |
4,273
+71
| +2% | +$5.46K | 0.13% | 242 |
|
|
2020
Q4 | $323K | Sell |
4,202
-832
| -17% | -$62.4K | 0.13% | 193 |
|
|
2020
Q3 | $376K | Sell |
5,034
-673
| -12% | -$44.9K | 0.2% | 176 |
|
|
2020
Q2 | $359K | Sell |
5,707
-1,943
| -25% | -$107K | 0.17% | 256 |
|
|
2020
Q1 | $321K | Sell |
7,650
-1,108
| -13% | -$50.8K | 0.13% | 219 |
|
|
2019
Q4 | $398K | Buy |
8,758
+4,174
| +91% | +$197K | 0.07% | 256 |
|
|
2019
Q3 | $210K | Sell |
4,584
-254
| -5% | -$14.3K | 0.04% | 240 |
|
|
2019
Q2 | $284K | Buy |
+4,838
| New | +$250K | 0.06% | 241 |
|
|
2016
Q4 | – | Sell |
-31,763
| Closed | -$556K | – | 199 |
|
|
2016
Q3 | $556K | Buy |
31,763
+4,002
| +14% | +$66.4K | 0.27% | 66 |
|
|
2016
Q2 | $475K | Sell |
27,761
-4,550
| -14% | -$81.3K | 0.35% | 62 |
|
|
2016
Q1 | $637K | Hold |
32,311
| – | – | 0.88% | 23 |
|
|
2015
Q4 | $614K | Buy |
+32,311
| New | +$659K | 1.69% | 17 |
|
Virtus ETF Advisers's ARNA Position: Q1 2022 in Review
Virtus ETF Advisers sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 1,785 shares — an estimated $166K sold.
Virtus ETF Advisers first reported a position in ARNA in Q4 2015 and held it in 15 quarters. The position peaked at $637K in Q1 2016. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Virtus ETF Advisers reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Virtus ETF Advisers sold 1,785 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $166K.
- Virtus ETF Advisers first reported a position in Arena Pharmaceuticals Inc in Q4 2015 and held it in 15 quarters.
- Virtus ETF Advisers's Arena Pharmaceuticals Inc position peaked at $637K in Q1 2016.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Virtus ETF Advisers's 13F filing for Q1 2022, filed 16 May 2022.